Hoff, Uwe
Markmann, Denise
Nieminen-Kelhä, Melina
Budde, Klemens
Hegner, Björn
Funding for this research was provided by:
Wyeth Pharmaceuticals
Charité - Universitätsmedizin Berlin
Article History
Received: 7 April 2021
Accepted: 16 July 2021
First Online: 11 August 2021
Competing interests
: Klemens Budde has received research funds and/or honoraria from Abbvie, Alexion, Astellas, Bristol-Myers Squibb, Chiesi, CSL Behring, Fresenius, Hexal, Hookipa Biotech, Merck Sharp & Dohme, Novartis, Otsuka, Pfizer, Roche, Shire, Siemens, Takeda, Veloxis and Vitaeris. All other authors declare no competing interests.